Biocon Biologics Ltd, the biosimilars unit of biopharmaceutical giant Biocon and its largest revenue driver, expects to ...

The gush of second quarter earnings reports is beginning to slow to a trickle, and with most of the reports in, the results ...

Stocks shook off last Friday’s sell-off with a positive week, but it wasn’t all smooth sailing. Tariff concerns weighed on stocks on Thursday and will continue to be a source of long-term uncertainty.